To evaluate the 6 months efficacy and safety of cyanoacrylate closure for the treatment of incompetent great saphenous veins (GSVs) in comparison with radiofrequency ablation (RFA).
Methods
In this multicenter, retrospective, clinical trial, 398 symptomatic subjects with incompetent GSVs were assigned to either cyanoacrylate closure or RFA. The primary endpoint, complete closure of the target GSV, was determined using duplex ultrasound examination starting from one-, three-, and six-month visits.
Results
All patients were followed for 6 months and there was no difference between the groups in terms of mean follow-up time. Hospital stay and return to work/activity were shorter in the cyanoacrylate ablation (CAA) group, and these differences between the groups were statistically significant. Ecchymosis was observed higher in the RFA group and was statistically significant.
Conclusions
In this study, in which we examined the CAA and RFA methods, we found that both methods were effective and reliable; however, we found that patients in the CAA group had a more comfortable postoperative period and returned to work earlier.
RabeEGuexJPuskasA, et al.Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol2012; 31: 105–115.
2.
EklofBPerrinMDelisKT, et al.Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document. J Vascsurg2009; 49: 498–501.
3.
ValenciaICFalabellaAKirsnerRS, et al.Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol2001; 44: 401–424.
4.
GibsonKFerrisB. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular2017; 25: 149–156.
5.
BalintRFaricsAPartiK, et al.Which endovenous ablation method does offer a better long-term technical success in the treatment of the incompetent great saphenous vein? Review. Vascular2016; 24: 649–657.
6.
Van den BosRArendsLKockaertM, et al.Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg2009; 49: 230–239.
7.
AnwarMALaneTRDaviesAH, et al.Complications of radiofrequency ablation. Phlebology2012; 27(Suppl 1): 34–39.
8.
DexterDKabnickLBerlandT, et al.Complications of endovenous lasers. Phebology2012; 27(Suppl 1): 40–45.
9.
LinfanteIWakhlooAK. Brain aneurysms and arteriovenous malformations: advancements and emerging treatments in endovascular embolization. Stroke2007; 38: 1411–1417.
10.
BrunoCAMeyersPM. Endovascular management of arteriovenous malformations of the brain. Interv Neurol2012; 1: 109–123.
11.
OgilvyCSStiegPEAwadI, et al.AHA scientific statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke2001; 32: 1458–1471.
12.
EliasSRainesJK. Mechanochemical tumescentlessendovenous ablation: final results of the initial clinical trial. Phlebology2012; 27: 67–72.
13.
MorrisonNGibsonKVasquezM, et al.VeClose trial 12-month outcomes of cyanoacrylate closure versus radiofrequency ablation for incompetent great saphenous veins. J VascSurg Venous Lymphat Disord2017; 5: 321–330.
14.
KleinJA. Tumescent technique chronicles: local anaesthesia, liposuction, and beyond. Dermatol Surg1995; 21: 449–457.
15.
YasimAErogluEBozoglanO, et al.A new non-tumescent endovenous ablation method for varicose vein treatment: early results of N-butyl cyanoacrylate (VariClose®). Phlebology2017; 32(3): 194–199. DOI: 10.1177/0268355516638577.
16.
MorrisonNGibsonKMcEnroeS, et al.Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg2015; 61: 985–994.
17.
KoramazIEl KilicHGokalpF, et al.Ablation of the great saphenous vein with nontumescent n-butyl cyanoacrylate versus endovenous laser therapy. J Vasc Surg Venous Lymphat Disord2017; 5: 210–215.
18.
ProebstleTMAlmJDimitriS, et al.The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord2015; 3: 2–7.
19.
KuklikESojkaMKarskaK, et al.Endovascular treatment of renal arteriovenous fistula with N-butyl cyanoacrylate (NBCA). Pol J Radiol2017; 82: 304–306.
20.
LunderquistABorjessonBOwmanT, et al.Isobutyl 2-cyanoacrylate (bucrylate) in obliteration of gastric Yang et al. 5 coronary vein and esophageal varices. Am J Roentgenol1978; 130: 1–6.
21.
LabenzJBorschG. Bleeding gastric and duodenal varicose veins: endoscopic embolisation using tissue adhesives. Dtsch Med Wochenschr1992; 117: 1274–1277.
22.
VanlangenhovePDe KeukeleireKEveraertK, et al.Efficacy and safety of two different n-butyl- 2-cyanoacrylates for the embolization of varicoceles: a prospective, randomized, blinded study. Cardiovasc Intervent Radiol2012; 35: 598–606.
23.
MaleuxGStockxLWilmsG, et al.Ovarian vein embolization for the treatment of pelvic congestion syndrome: long-term technical and clinical results. J Vasc Interv Radiol2000; 11: 859–864.
24.
LawsonJGauwSvan VlijmenC, et al.Sapheon: the solution?Phlebology2013; 28: 2–9.
25.
National Institute for Health and Care Excellence. Varicose veins in the legs. The diagnosis and management of varicose veins. London, UK: National Institute for Health and Care Excellence, 2013. https://www.nice.org.uk/guidance/cg168.
26.
GloviczkiPComerotaAJDalsingMC, et al.The care of patients with varicose veins and associated chronicvenous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg2011; 53: 2S–48S.
27.
HashimotoOMiyazakiTHosokawaJ, et al.A case of high-output heart failure caused by a femoralarteriovenous fistula after endovenous laser ablation treatment of the saphenous vein. Phlebology2015; 30: 290–292.
28.
OstlerAEHoldstockJMHarrisonCC, et al.Arterial false aneurysm in the groin following endovenous laser ablation. Phlebology2015; 30: 220–222.
29.
Medical Advisory Secretariat. Endovascular radiofrequency ablation for varicose veins: an evidencebased analysis. Ontario Health Technol Assess Ser2011; 11: 1–93.
30.
ZunigaJMHingoraniAAscherE, et al.Short-term outcome analysis of radiofrequency ablation using ClosurePlus vs ClosureFast catheters in the treatment of incompetent great saphenous vein. J Vasc Surg2012; 55: 1048–1051.
31.
AlmeidaJIJavierJJMackayEG, et al.Two-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. Phlebology2015; 30: 397–404.
32.
ProebstleTMAlmJDimitriS, et al.Twelve-month follow-up of the European multicenter study on cyanoacrylate embolization of incompetent great saphenous veins. J Vasc Surg2014; 2: 105–106.
33.
GibsonKMorrisonNKolluriR, et al.Twenty-four-month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous and Lymphatic Disord2018; 6(5), 606–613. DOI: 10.1016/j.jvsv.2018.04.009.
34.
ErdincEAlptekinY. A randomised clinical trial comparing n-butyl cyanoacrylate, radiofrequency ablation and endovenous laser ablation for the treatment of superficial venous incompetence: two year follow up results. Eur J Vasc Endovasc Surg2018; 56(4), 553–560.
